NCT01985373 - Pharmacokinetics and Safety of IVIG Nanogam 100 mg/ml | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions

Primary Immunodeficiency

Interventions

DRUG

Intravenous immunoglobulin infusion

Blood samples are drawn before infusion with Nanogam 50 and Nanogam 100 mg/ml and IgG levels are determined to study PK

Trial Locations (4)

Jeroen Bosch Ziekenhuis, 's-Hertogenbosch

UMCG, Groningen

LUMC, Leiden

UMC St. Radboud, Nijmegen